|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 38/17 | |
| A61K 39/395 | |||
| C07K 16/28 | |||
| A61P 37/06 |
| (11) | Patento numeris | 1294391 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 01942118.9 |
| Europos patento paraiškos padavimo data | 2001-06-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2003-03-26 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-08-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2001/018619 |
| Data | 2001-06-08 |
| (87) | Numeris | WO 2001/095928 |
| Data | 2001-12-20 |
| (30) | Numeris | Data | Šalis |
| 210671 P | 2000-06-09 | US |
| (72) |
TOWNSEND, Robert, M., US
TODDERUD, Charles, Gordon, US
PEACH, Robert, J., US
|
| (73) |
Bristol-Myers Squibb Company,
Lawrenceville-Princeton Road P.O. Box 4000, Princeton NJ 08543-4000,
US
|
| (54) | COMBINATION OF AGENTS FOR INHIBITING TRANSPLANT REJECTION |
| COMBINATION OF AGENTS FOR INHIBITING TRANSPLANT REJECTION |